METTL3 and early-onset autosomal dominant Alzheimer disease: This study reveals that loss of METTL3, and the corresponding changes in m6A modifications, leads to enhanced brain infiltration of monocyte-derived macrophages in a mouse model of Alzheimer’s Disease, promoting Aβ clearance and ameliorating pathology and cognitive decline.